Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,429 | 242 | 99.3% |
| Education | $40.54 | 4 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,797 | 28 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $690.87 | 46 | $0 (2024) |
| ABBVIE INC. | $367.29 | 18 | $0 (2024) |
| Lilly USA, LLC | $310.17 | 19 | $0 (2024) |
| PFIZER INC. | $283.86 | 22 | $0 (2024) |
| Novo Nordisk Inc | $240.71 | 14 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $174.65 | 14 | $0 (2023) |
| Boston Scientific Corporation | $171.97 | 2 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $142.91 | 8 | $0 (2024) |
| GlaxoSmithKline, LLC. | $135.20 | 10 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $671.54 | 29 | Amgen Inc. ($173.82) |
| 2023 | $1,260 | 47 | Amgen Inc. ($615.94) |
| 2022 | $1,610 | 42 | Amgen Inc. ($973.60) |
| 2020 | $135.42 | 9 | AstraZeneca Pharmaceuticals LP ($39.33) |
| 2019 | $721.67 | 41 | AstraZeneca Pharmaceuticals LP ($226.55) |
| 2018 | $658.43 | 48 | AstraZeneca Pharmaceuticals LP ($179.13) |
| 2017 | $412.54 | 30 | AstraZeneca Pharmaceuticals LP ($112.87) |
All Payment Transactions
246 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: PAIN | ||||||
| 12/05/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $115.16 | General |
| Category: Cardiology | ||||||
| 11/19/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Obesity | ||||||
| 09/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: NEUROSCIENCE | ||||||
| 08/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/06/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: PAIN | ||||||
| 07/16/2024 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Neuroscience | ||||||
| 07/10/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/09/2024 | Stryker Corporation | AEQUALIS PERFORM (Device) | Food and Beverage | In-kind items and services | $29.56 | General |
| Category: TRAUMA & EXTREMITIES | ||||||
| 07/02/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: Endocrinology | ||||||
| 06/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: PSYCHIATRY | ||||||
| 05/15/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Oncology | ||||||
| 05/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: Inflammation | ||||||
| 04/30/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 04/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Diabetes | ||||||
| 03/19/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Diabetes | ||||||
| 03/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $4.68 | General |
| Category: Inflammation | ||||||
| 03/06/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: NEUROSCIENCE | ||||||
| 02/27/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 369 | 516 | $67,475 | $28,036 |
| 2022 | 8 | 357 | 536 | $63,402 | $24,932 |
| 2021 | 8 | 388 | 563 | $60,910 | $28,521 |
| 2020 | 7 | 393 | 610 | $62,891 | $25,192 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 92 | 171 | $40,401 | $11,336 | 28.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 98 | 98 | $13,720 | $11,176 | 81.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 50 | 57 | $9,537 | $2,659 | 27.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 98 | 159 | $1,590 | $1,304 | 82.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 15 | 15 | $1,395 | $1,137 | 81.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 16 | 16 | $832.00 | $424.80 | 51.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 98 | 204 | $42,898 | $13,021 | 30.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 61 | 61 | $8,540 | $7,274 | 85.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 38 | 43 | $6,333 | $1,956 | 30.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 18 | 18 | $1,620 | $1,265 | 78.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 20 | 21 | $1,038 | $537.30 | 51.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 98 | 160 | $1,600 | $457.03 | 28.6% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 11 | 11 | $1,265 | $366.31 | 29.0% |
| 81002 | Urinalysis, manual test | Office | 2022 | 13 | 18 | $108.00 | $56.14 | 52.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 97 | 194 | $37,830 | $13,297 | 35.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 84 | 84 | $11,365 | $10,158 | 89.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 44 | 47 | $6,251 | $2,340 | 37.4% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 14 | 14 | $1,120 | $848.38 | 75.7% |
| 0003A | Fee covid-19 vac 1 booster | Office | 2021 | 18 | 18 | $1,072 | $658.62 | 61.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 101 | 176 | $1,760 | $515.61 | 29.3% |
| 0064A | Fee covid-19 vac 7 res | Office | 2021 | 12 | 12 | $720.00 | $439.08 | 61.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 18 | 18 | $792.00 | $264.88 | 33.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 92 | 195 | $38,042 | $11,563 | 30.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 75 | 75 | $9,000 | $8,033 | 89.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 60 | 85 | $11,305 | $3,419 | 30.2% |
About Dr. Ryan Moore, MD
Dr. Ryan Moore, MD is a Family Medicine healthcare provider based in Boise, Idaho. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386664654.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Moore, MD has received a total of $5,470 in payments from pharmaceutical and medical device companies, with $671.54 received in 2024. These payments were reported across 246 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($5,429).
As a Medicare-enrolled provider, Moore has provided services to 1,507 Medicare beneficiaries, totaling 2,225 services with total Medicare billing of $106,682. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Boise, ID
- Active Since 07/20/2006
- Last Updated 09/23/2014
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1386664654
Products in Payments
- Repatha (Biological) $1,685
- FARXIGA (Drug) $438.43
- SYMBICORT (Drug) $221.42
- UBRELVY (Drug) $196.97
- QULIPTA (Drug) $134.09
- EMGALITY (Drug) $124.98
- CHANTIX (Drug) $120.34
- GENERAL VASCULAR INTERVENTION (Device) $114.54
- XARELTO (Drug) $111.82
- Trintellix (Drug) $111.52
- ENTRESTO (Drug) $96.18
- Ozempic (Drug) $82.36
- TRULICITY (Drug) $73.67
- SOLIQUA 100/33 (Biological) $73.29
- ELIQUIS (Drug) $72.41
- EVENITY (Biological) $60.77
- TRELEGY ELLIPTA (Drug) $60.20
- VRAYLAR (Drug) $59.22
- Rybelsus (Drug) $58.58
- Lumenis Pulse 120H (Device) $57.43
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Boise
Brock Mcconnehey, Do, DO
Family Medicine — Payments: $309,232
Phyllis You, Md, MD
Family Medicine — Payments: $94,236
Dr. Kara Cadwallader, M.d, M.D
Family Medicine — Payments: $17,998
Cyrus Vania, Do, DO
Family Medicine — Payments: $9,541
Dr. Donald Hartman, Md, MD
Family Medicine — Payments: $9,339
Dr. Joshua Adams, M.d, M.D
Family Medicine — Payments: $6,481